164 related articles for article (PubMed ID: 25039405)
1. Single-chain factor XII exhibits activity when complexed to polyphosphate.
Engel R; Brain CM; Paget J; Lionikiene AS; Mutch NJ
J Thromb Haemost; 2014 Sep; 12(9):1513-22. PubMed ID: 25039405
[TBL] [Abstract][Full Text] [Related]
2. Polyphosphate colocalizes with factor XII on platelet-bound fibrin and augments its plasminogen activator activity.
Mitchell JL; Lionikiene AS; Georgiev G; Klemmer A; Brain C; Kim PY; Mutch NJ
Blood; 2016 Dec; 128(24):2834-2845. PubMed ID: 27694320
[TBL] [Abstract][Full Text] [Related]
3. The Fibronectin Type II Domain of Factor XII Ensures Zymogen Quiescence.
Clark CC; Hofman ZLM; Sanrattana W; den Braven L; de Maat S; Maas C
Thromb Haemost; 2020 Mar; 120(3):400-411. PubMed ID: 31940673
[TBL] [Abstract][Full Text] [Related]
4. Factor XII promotes blood coagulation independent of factor XI in the presence of long-chain polyphosphates.
Puy C; Tucker EI; Wong ZC; Gailani D; Smith SA; Choi SH; Morrissey JH; Gruber A; McCarty OJ
J Thromb Haemost; 2013 Jul; 11(7):1341-52. PubMed ID: 23659638
[TBL] [Abstract][Full Text] [Related]
5. Enzymes produced by autoactivation of blood factor XII in buffer: A contribution from the Hematology at Biomaterial Interfaces Research Group.
Golas A; Pitakjakpipop H; Rahn MS; Siedlecki CA; Vogler EA
Biomaterials; 2015 Jan; 37():1-12. PubMed ID: 25443791
[TBL] [Abstract][Full Text] [Related]
6. Proteolytic properties of single-chain factor XII: a mechanism for triggering contact activation.
Ivanov I; Matafonov A; Sun MF; Cheng Q; Dickeson SK; Verhamme IM; Emsley J; Gailani D
Blood; 2017 Mar; 129(11):1527-1537. PubMed ID: 28069606
[TBL] [Abstract][Full Text] [Related]
7. The second exon-encoded factor XII region is involved in the interaction of factor XII with factor XI and does not contribute to the binding site for negatively charged surfaces.
Citarella F; Fedele G; Roem D; Fantoni A; Hack CE
Blood; 1998 Dec; 92(11):4198-206. PubMed ID: 9834224
[TBL] [Abstract][Full Text] [Related]
8. Polyphosphate, Zn
Wang Y; Ivanov I; Smith SA; Gailani D; Morrissey JH
J Thromb Haemost; 2019 Dec; 17(12):2131-2140. PubMed ID: 31420909
[TBL] [Abstract][Full Text] [Related]
9. Proteolytic activity of contact factor zymogens.
Shamanaev A; Emsley J; Gailani D
J Thromb Haemost; 2021 Feb; 19(2):330-341. PubMed ID: 33107140
[TBL] [Abstract][Full Text] [Related]
10. A mechanism for hereditary angioedema with normal C1 inhibitor: an inhibitory regulatory role for the factor XII heavy chain.
Ivanov I; Matafonov A; Sun MF; Mohammed BM; Cheng Q; Dickeson SK; Kundu S; Verhamme IM; Gruber A; McCrae K; Gailani D
Blood; 2019 Mar; 133(10):1152-1163. PubMed ID: 30591525
[TBL] [Abstract][Full Text] [Related]
11. Mechanism of surface-mediated activation of bovine Factor XII and prekallikrein.
Sugo T; Ohno Y; Shimada T; Kato H; Iwanaga S
Adv Exp Med Biol; 1983; 156():87-107. PubMed ID: 6602465
[TBL] [Abstract][Full Text] [Related]
12. Factor XII Activation Promotes Platelet Consumption in the Presence of Bacterial-Type Long-Chain Polyphosphate In Vitro and In Vivo.
Zilberman-Rudenko J; Reitsma SE; Puy C; Rigg RA; Smith SA; Tucker EI; Silasi R; Merkulova A; McCrae KR; Maas C; Urbanus RT; Gailani D; Morrissey JH; Gruber A; Lupu F; Schmaier AH; McCarty OJT
Arterioscler Thromb Vasc Biol; 2018 Aug; 38(8):1748-1760. PubMed ID: 30354195
[TBL] [Abstract][Full Text] [Related]
13. Identification of the histidine-rich glycoprotein domains responsible for contact pathway inhibition.
Truong TK; Malik RA; Yao X; Fredenburgh JC; Stafford AR; Madarati HM; Kretz CA; Weitz JI
J Thromb Haemost; 2022 Apr; 20(4):821-832. PubMed ID: 34967109
[TBL] [Abstract][Full Text] [Related]
14. A site on factor XII required for productive interactions with polyphosphate.
Shamanaev A; Litvak M; Cheng Q; Ponczek M; Dickeson SK; Smith SA; Morrissey JH; Gailani D
J Thromb Haemost; 2023 Jun; 21(6):1567-1579. PubMed ID: 36863563
[TBL] [Abstract][Full Text] [Related]
15. Model for surface-dependent factor XII activation: the roles of factor XII heavy chain domains.
Shamanaev A; Ivanov I; Sun MF; Litvak M; Srivastava P; Mohammed BM; Shaban R; Maddur A; Verhamme IM; McCarty OJT; Law RHP; Gailani D
Blood Adv; 2022 May; 6(10):3142-3154. PubMed ID: 35086137
[TBL] [Abstract][Full Text] [Related]
16. Coagulation factor XII protease domain crystal structure.
Pathak M; Wilmann P; Awford J; Li C; Hamad BK; Fischer PM; Dreveny I; Dekker LV; Emsley J
J Thromb Haemost; 2015 Apr; 13(4):580-91. PubMed ID: 25604127
[TBL] [Abstract][Full Text] [Related]
17. Functional characterization of a variant factor XII (F XII Locarno) in a cross reacting material positive F XII deficient plasma.
Wuillemin WA; Furlan M; Stricker H; Lämmle B
Thromb Haemost; 1992 Feb; 67(2):219-25. PubMed ID: 1621242
[TBL] [Abstract][Full Text] [Related]
18. Titanium is a potent inducer of contact activation: implications for intravascular devices.
Litvak M; Shamanaev A; Zalawadiya S; Matafonov A; Kobrin A; Feener EP; Wallisch M; Tucker EI; McCarty OJT; Gailani D
J Thromb Haemost; 2023 May; 21(5):1200-1213. PubMed ID: 36696212
[TBL] [Abstract][Full Text] [Related]
19. Identification of a putative binding site for negatively charged surfaces in the fibronectin type II domain of human factor XII--an immunochemical and homology modeling approach.
Citarella F; te Velthuis H; Helmer-Citterich M; Hack CE
Thromb Haemost; 2000 Dec; 84(6):1057-65. PubMed ID: 11154114
[TBL] [Abstract][Full Text] [Related]
20. Structure/function analysis of human factor XII using recombinant deletion mutants. Evidence for an additional region involved in the binding to negatively charged surfaces.
Citarella F; Ravon DM; Pascucci B; Felici A; Fantoni A; Hack CE
Eur J Biochem; 1996 May; 238(1):240-9. PubMed ID: 8665943
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
